Human cytomegalovirus protein RL1 degrades the antiviral factor SLFN11 via recruitment of the CRL4 E3 ubiquitin ligase complex

Human cytomegalovirus (HCMV) is an important human pathogen and a paradigm of viral immune evasion, targeting intrinsic, innate, and adaptive immunity. We have employed two orthogonal multiplexed tandem mass tag-based proteomic screens to identify host proteins down-regulated by viral factors expres...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Proceedings of the National Academy of Sciences - PNAS 2022-02, Vol.119 (6), p.1-7
Hauptverfasser: Nightingale, Katie, Potts, Martin, Hunter, Leah M., Fielding, Ceri A., Zerbe, Cassie M., Fletcher-Etherington, Alice, Nobre, Luis, Wang, Eddie C. Y., Strang, Blair L., Houghton, Jack W., Antrobus, Robin, Suarez, Nicolas M., Nichols, Jenna, Davison, Andrew J., Stanton, Richard J., Weekes, Michael P.
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 7
container_issue 6
container_start_page 1
container_title Proceedings of the National Academy of Sciences - PNAS
container_volume 119
creator Nightingale, Katie
Potts, Martin
Hunter, Leah M.
Fielding, Ceri A.
Zerbe, Cassie M.
Fletcher-Etherington, Alice
Nobre, Luis
Wang, Eddie C. Y.
Strang, Blair L.
Houghton, Jack W.
Antrobus, Robin
Suarez, Nicolas M.
Nichols, Jenna
Davison, Andrew J.
Stanton, Richard J.
Weekes, Michael P.
description Human cytomegalovirus (HCMV) is an important human pathogen and a paradigm of viral immune evasion, targeting intrinsic, innate, and adaptive immunity. We have employed two orthogonal multiplexed tandem mass tag-based proteomic screens to identify host proteins down-regulated by viral factors expressed during the latest phases of viral infection. This approach revealed that the HIV-1 restriction factor Schlafen-11 (SLFN11) was degraded by the poorly characterized, late-expressed HCMV protein RL1, via recruitment of the Cullin4-RING E3 Ubiquitin Ligase (CRL4) complex. SLFN11 potently restricted HCMV infection, inhibiting the formation and spread of viral plaques. Overall, we show that a restriction factor previously thought only to inhibit RNA viruses additionally restricts HCMV. We define the mechanism of viral antagonism and also describe an important resource for revealing additional molecules of importance in antiviral innate immunity and viral immune evasion.
doi_str_mv 10.1073/pnas.2108173119
format Article
fullrecord <record><control><sourceid>jstor_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_8832970</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><jstor_id>27118546</jstor_id><sourcerecordid>27118546</sourcerecordid><originalsourceid>FETCH-LOGICAL-c443t-1b6f655188eb3f10454993c9cdc9ef63a7641512af0fdf21940d7c5eef65da4d3</originalsourceid><addsrcrecordid>eNpdkUFv1DAQhS0EokvhzAlkiUsvaT22k9gXJLRqKVJEpQJny-vYW6-SOLWTVXvpb6-XLQv0NJbe5zfz9BB6D-QUSM3OxkGnUwpEQM0A5Au0ACKhqLgkL9GCEFoXglN-hN6ktCGEyFKQ1-iIlUDyiy7Qw-Xc6wGb-yn0dq27sPVxTniMYbJ-wNcN4Nauo25twtONxXqYfEZ0h502U4j4R3PxHQBvvcbRmjj7qbfDhIP7jS-vG47PGZ5X_jZL2bHza50sNqEfO3v3Fr1yukv23dM8Rr8uzn8uL4vm6uu35ZemMJyzqYBV5aqyBCHsijkgvORSMiNNa6R1FdN1xaEEqh1xraMgOWlrU9qsla3mLTtGn_e-47zqbWvyiTmDGqPvdbxXQXv1vzL4G7UOWyUEo7Im2eDkySCG29mmSfU-Gdt1erBhTopWlEsuiGAZ_fQM3YQ5Djnejsp-dc2rTJ3tKRNDStG6wzFA1K5btetW_e02__j4b4YD_6fMDHzYA5uUmznotAYQZV75CBLCquc</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2628327746</pqid></control><display><type>article</type><title>Human cytomegalovirus protein RL1 degrades the antiviral factor SLFN11 via recruitment of the CRL4 E3 ubiquitin ligase complex</title><source>MEDLINE</source><source>PubMed Central</source><source>Alma/SFX Local Collection</source><source>Free Full-Text Journals in Chemistry</source><creator>Nightingale, Katie ; Potts, Martin ; Hunter, Leah M. ; Fielding, Ceri A. ; Zerbe, Cassie M. ; Fletcher-Etherington, Alice ; Nobre, Luis ; Wang, Eddie C. Y. ; Strang, Blair L. ; Houghton, Jack W. ; Antrobus, Robin ; Suarez, Nicolas M. ; Nichols, Jenna ; Davison, Andrew J. ; Stanton, Richard J. ; Weekes, Michael P.</creator><creatorcontrib>Nightingale, Katie ; Potts, Martin ; Hunter, Leah M. ; Fielding, Ceri A. ; Zerbe, Cassie M. ; Fletcher-Etherington, Alice ; Nobre, Luis ; Wang, Eddie C. Y. ; Strang, Blair L. ; Houghton, Jack W. ; Antrobus, Robin ; Suarez, Nicolas M. ; Nichols, Jenna ; Davison, Andrew J. ; Stanton, Richard J. ; Weekes, Michael P.</creatorcontrib><description>Human cytomegalovirus (HCMV) is an important human pathogen and a paradigm of viral immune evasion, targeting intrinsic, innate, and adaptive immunity. We have employed two orthogonal multiplexed tandem mass tag-based proteomic screens to identify host proteins down-regulated by viral factors expressed during the latest phases of viral infection. This approach revealed that the HIV-1 restriction factor Schlafen-11 (SLFN11) was degraded by the poorly characterized, late-expressed HCMV protein RL1, via recruitment of the Cullin4-RING E3 Ubiquitin Ligase (CRL4) complex. SLFN11 potently restricted HCMV infection, inhibiting the formation and spread of viral plaques. Overall, we show that a restriction factor previously thought only to inhibit RNA viruses additionally restricts HCMV. We define the mechanism of viral antagonism and also describe an important resource for revealing additional molecules of importance in antiviral innate immunity and viral immune evasion.</description><identifier>ISSN: 0027-8424</identifier><identifier>EISSN: 1091-6490</identifier><identifier>DOI: 10.1073/pnas.2108173119</identifier><identifier>PMID: 35105802</identifier><language>eng</language><publisher>United States: National Academy of Sciences</publisher><subject>Adaptive immunity ; Biological Sciences ; Cytomegalovirus ; Cytomegalovirus - genetics ; Cytomegalovirus - immunology ; Cytomegalovirus Infections - genetics ; Cytomegalovirus Infections - immunology ; HIV ; Human immunodeficiency virus ; Humans ; Immune Evasion ; Immunity ; Innate immunity ; Nuclear Proteins - genetics ; Nuclear Proteins - immunology ; Plaques ; Proteins ; Proteolysis ; Proteomics ; Recruitment ; RNA viruses ; Ubiquitin ; Ubiquitin-protein ligase ; Ubiquitin-Protein Ligase Complexes - genetics ; Ubiquitin-Protein Ligase Complexes - immunology ; Viral Envelope Proteins - genetics ; Viral Envelope Proteins - immunology ; Viral infections</subject><ispartof>Proceedings of the National Academy of Sciences - PNAS, 2022-02, Vol.119 (6), p.1-7</ispartof><rights>Copyright © 2022 the Author(s). Published by PNAS.</rights><rights>Copyright National Academy of Sciences Feb 8, 2022</rights><rights>Copyright © 2022 the Author(s). Published by PNAS. 2022</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c443t-1b6f655188eb3f10454993c9cdc9ef63a7641512af0fdf21940d7c5eef65da4d3</citedby><cites>FETCH-LOGICAL-c443t-1b6f655188eb3f10454993c9cdc9ef63a7641512af0fdf21940d7c5eef65da4d3</cites><orcidid>0000-0001-8429-8374 ; 0000-0001-9407-1974 ; 0000-0002-6799-1182 ; 0000-0003-0467-8989 ; 0000-0003-3196-5545 ; 0000-0001-7313-9247 ; 0000-0001-9958-4699 ; 0000-0002-4991-9128 ; 0000-0002-6738-0066 ; 0000-0002-0000-5712 ; 0000-0003-0093-7170 ; 0000-0002-2243-4964</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC8832970/pdf/$$EPDF$$P50$$Gpubmedcentral$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC8832970/$$EHTML$$P50$$Gpubmedcentral$$Hfree_for_read</linktohtml><link.rule.ids>230,314,723,776,780,881,27901,27902,53766,53768</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/35105802$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Nightingale, Katie</creatorcontrib><creatorcontrib>Potts, Martin</creatorcontrib><creatorcontrib>Hunter, Leah M.</creatorcontrib><creatorcontrib>Fielding, Ceri A.</creatorcontrib><creatorcontrib>Zerbe, Cassie M.</creatorcontrib><creatorcontrib>Fletcher-Etherington, Alice</creatorcontrib><creatorcontrib>Nobre, Luis</creatorcontrib><creatorcontrib>Wang, Eddie C. Y.</creatorcontrib><creatorcontrib>Strang, Blair L.</creatorcontrib><creatorcontrib>Houghton, Jack W.</creatorcontrib><creatorcontrib>Antrobus, Robin</creatorcontrib><creatorcontrib>Suarez, Nicolas M.</creatorcontrib><creatorcontrib>Nichols, Jenna</creatorcontrib><creatorcontrib>Davison, Andrew J.</creatorcontrib><creatorcontrib>Stanton, Richard J.</creatorcontrib><creatorcontrib>Weekes, Michael P.</creatorcontrib><title>Human cytomegalovirus protein RL1 degrades the antiviral factor SLFN11 via recruitment of the CRL4 E3 ubiquitin ligase complex</title><title>Proceedings of the National Academy of Sciences - PNAS</title><addtitle>Proc Natl Acad Sci U S A</addtitle><description>Human cytomegalovirus (HCMV) is an important human pathogen and a paradigm of viral immune evasion, targeting intrinsic, innate, and adaptive immunity. We have employed two orthogonal multiplexed tandem mass tag-based proteomic screens to identify host proteins down-regulated by viral factors expressed during the latest phases of viral infection. This approach revealed that the HIV-1 restriction factor Schlafen-11 (SLFN11) was degraded by the poorly characterized, late-expressed HCMV protein RL1, via recruitment of the Cullin4-RING E3 Ubiquitin Ligase (CRL4) complex. SLFN11 potently restricted HCMV infection, inhibiting the formation and spread of viral plaques. Overall, we show that a restriction factor previously thought only to inhibit RNA viruses additionally restricts HCMV. We define the mechanism of viral antagonism and also describe an important resource for revealing additional molecules of importance in antiviral innate immunity and viral immune evasion.</description><subject>Adaptive immunity</subject><subject>Biological Sciences</subject><subject>Cytomegalovirus</subject><subject>Cytomegalovirus - genetics</subject><subject>Cytomegalovirus - immunology</subject><subject>Cytomegalovirus Infections - genetics</subject><subject>Cytomegalovirus Infections - immunology</subject><subject>HIV</subject><subject>Human immunodeficiency virus</subject><subject>Humans</subject><subject>Immune Evasion</subject><subject>Immunity</subject><subject>Innate immunity</subject><subject>Nuclear Proteins - genetics</subject><subject>Nuclear Proteins - immunology</subject><subject>Plaques</subject><subject>Proteins</subject><subject>Proteolysis</subject><subject>Proteomics</subject><subject>Recruitment</subject><subject>RNA viruses</subject><subject>Ubiquitin</subject><subject>Ubiquitin-protein ligase</subject><subject>Ubiquitin-Protein Ligase Complexes - genetics</subject><subject>Ubiquitin-Protein Ligase Complexes - immunology</subject><subject>Viral Envelope Proteins - genetics</subject><subject>Viral Envelope Proteins - immunology</subject><subject>Viral infections</subject><issn>0027-8424</issn><issn>1091-6490</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2022</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNpdkUFv1DAQhS0EokvhzAlkiUsvaT22k9gXJLRqKVJEpQJny-vYW6-SOLWTVXvpb6-XLQv0NJbe5zfz9BB6D-QUSM3OxkGnUwpEQM0A5Au0ACKhqLgkL9GCEFoXglN-hN6ktCGEyFKQ1-iIlUDyiy7Qw-Xc6wGb-yn0dq27sPVxTniMYbJ-wNcN4Nauo25twtONxXqYfEZ0h502U4j4R3PxHQBvvcbRmjj7qbfDhIP7jS-vG47PGZ5X_jZL2bHza50sNqEfO3v3Fr1yukv23dM8Rr8uzn8uL4vm6uu35ZemMJyzqYBV5aqyBCHsijkgvORSMiNNa6R1FdN1xaEEqh1xraMgOWlrU9qsla3mLTtGn_e-47zqbWvyiTmDGqPvdbxXQXv1vzL4G7UOWyUEo7Im2eDkySCG29mmSfU-Gdt1erBhTopWlEsuiGAZ_fQM3YQ5Djnejsp-dc2rTJ3tKRNDStG6wzFA1K5btetW_e02__j4b4YD_6fMDHzYA5uUmznotAYQZV75CBLCquc</recordid><startdate>20220208</startdate><enddate>20220208</enddate><creator>Nightingale, Katie</creator><creator>Potts, Martin</creator><creator>Hunter, Leah M.</creator><creator>Fielding, Ceri A.</creator><creator>Zerbe, Cassie M.</creator><creator>Fletcher-Etherington, Alice</creator><creator>Nobre, Luis</creator><creator>Wang, Eddie C. Y.</creator><creator>Strang, Blair L.</creator><creator>Houghton, Jack W.</creator><creator>Antrobus, Robin</creator><creator>Suarez, Nicolas M.</creator><creator>Nichols, Jenna</creator><creator>Davison, Andrew J.</creator><creator>Stanton, Richard J.</creator><creator>Weekes, Michael P.</creator><general>National Academy of Sciences</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7QG</scope><scope>7QL</scope><scope>7QP</scope><scope>7QR</scope><scope>7SN</scope><scope>7SS</scope><scope>7T5</scope><scope>7TK</scope><scope>7TM</scope><scope>7TO</scope><scope>7U9</scope><scope>8FD</scope><scope>C1K</scope><scope>FR3</scope><scope>H94</scope><scope>M7N</scope><scope>P64</scope><scope>RC3</scope><scope>7X8</scope><scope>5PM</scope><orcidid>https://orcid.org/0000-0001-8429-8374</orcidid><orcidid>https://orcid.org/0000-0001-9407-1974</orcidid><orcidid>https://orcid.org/0000-0002-6799-1182</orcidid><orcidid>https://orcid.org/0000-0003-0467-8989</orcidid><orcidid>https://orcid.org/0000-0003-3196-5545</orcidid><orcidid>https://orcid.org/0000-0001-7313-9247</orcidid><orcidid>https://orcid.org/0000-0001-9958-4699</orcidid><orcidid>https://orcid.org/0000-0002-4991-9128</orcidid><orcidid>https://orcid.org/0000-0002-6738-0066</orcidid><orcidid>https://orcid.org/0000-0002-0000-5712</orcidid><orcidid>https://orcid.org/0000-0003-0093-7170</orcidid><orcidid>https://orcid.org/0000-0002-2243-4964</orcidid></search><sort><creationdate>20220208</creationdate><title>Human cytomegalovirus protein RL1 degrades the antiviral factor SLFN11 via recruitment of the CRL4 E3 ubiquitin ligase complex</title><author>Nightingale, Katie ; Potts, Martin ; Hunter, Leah M. ; Fielding, Ceri A. ; Zerbe, Cassie M. ; Fletcher-Etherington, Alice ; Nobre, Luis ; Wang, Eddie C. Y. ; Strang, Blair L. ; Houghton, Jack W. ; Antrobus, Robin ; Suarez, Nicolas M. ; Nichols, Jenna ; Davison, Andrew J. ; Stanton, Richard J. ; Weekes, Michael P.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c443t-1b6f655188eb3f10454993c9cdc9ef63a7641512af0fdf21940d7c5eef65da4d3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2022</creationdate><topic>Adaptive immunity</topic><topic>Biological Sciences</topic><topic>Cytomegalovirus</topic><topic>Cytomegalovirus - genetics</topic><topic>Cytomegalovirus - immunology</topic><topic>Cytomegalovirus Infections - genetics</topic><topic>Cytomegalovirus Infections - immunology</topic><topic>HIV</topic><topic>Human immunodeficiency virus</topic><topic>Humans</topic><topic>Immune Evasion</topic><topic>Immunity</topic><topic>Innate immunity</topic><topic>Nuclear Proteins - genetics</topic><topic>Nuclear Proteins - immunology</topic><topic>Plaques</topic><topic>Proteins</topic><topic>Proteolysis</topic><topic>Proteomics</topic><topic>Recruitment</topic><topic>RNA viruses</topic><topic>Ubiquitin</topic><topic>Ubiquitin-protein ligase</topic><topic>Ubiquitin-Protein Ligase Complexes - genetics</topic><topic>Ubiquitin-Protein Ligase Complexes - immunology</topic><topic>Viral Envelope Proteins - genetics</topic><topic>Viral Envelope Proteins - immunology</topic><topic>Viral infections</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Nightingale, Katie</creatorcontrib><creatorcontrib>Potts, Martin</creatorcontrib><creatorcontrib>Hunter, Leah M.</creatorcontrib><creatorcontrib>Fielding, Ceri A.</creatorcontrib><creatorcontrib>Zerbe, Cassie M.</creatorcontrib><creatorcontrib>Fletcher-Etherington, Alice</creatorcontrib><creatorcontrib>Nobre, Luis</creatorcontrib><creatorcontrib>Wang, Eddie C. Y.</creatorcontrib><creatorcontrib>Strang, Blair L.</creatorcontrib><creatorcontrib>Houghton, Jack W.</creatorcontrib><creatorcontrib>Antrobus, Robin</creatorcontrib><creatorcontrib>Suarez, Nicolas M.</creatorcontrib><creatorcontrib>Nichols, Jenna</creatorcontrib><creatorcontrib>Davison, Andrew J.</creatorcontrib><creatorcontrib>Stanton, Richard J.</creatorcontrib><creatorcontrib>Weekes, Michael P.</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Animal Behavior Abstracts</collection><collection>Bacteriology Abstracts (Microbiology B)</collection><collection>Calcium &amp; Calcified Tissue Abstracts</collection><collection>Chemoreception Abstracts</collection><collection>Ecology Abstracts</collection><collection>Entomology Abstracts (Full archive)</collection><collection>Immunology Abstracts</collection><collection>Neurosciences Abstracts</collection><collection>Nucleic Acids Abstracts</collection><collection>Oncogenes and Growth Factors Abstracts</collection><collection>Virology and AIDS Abstracts</collection><collection>Technology Research Database</collection><collection>Environmental Sciences and Pollution Management</collection><collection>Engineering Research Database</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>Algology Mycology and Protozoology Abstracts (Microbiology C)</collection><collection>Biotechnology and BioEngineering Abstracts</collection><collection>Genetics Abstracts</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Proceedings of the National Academy of Sciences - PNAS</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Nightingale, Katie</au><au>Potts, Martin</au><au>Hunter, Leah M.</au><au>Fielding, Ceri A.</au><au>Zerbe, Cassie M.</au><au>Fletcher-Etherington, Alice</au><au>Nobre, Luis</au><au>Wang, Eddie C. Y.</au><au>Strang, Blair L.</au><au>Houghton, Jack W.</au><au>Antrobus, Robin</au><au>Suarez, Nicolas M.</au><au>Nichols, Jenna</au><au>Davison, Andrew J.</au><au>Stanton, Richard J.</au><au>Weekes, Michael P.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Human cytomegalovirus protein RL1 degrades the antiviral factor SLFN11 via recruitment of the CRL4 E3 ubiquitin ligase complex</atitle><jtitle>Proceedings of the National Academy of Sciences - PNAS</jtitle><addtitle>Proc Natl Acad Sci U S A</addtitle><date>2022-02-08</date><risdate>2022</risdate><volume>119</volume><issue>6</issue><spage>1</spage><epage>7</epage><pages>1-7</pages><issn>0027-8424</issn><eissn>1091-6490</eissn><abstract>Human cytomegalovirus (HCMV) is an important human pathogen and a paradigm of viral immune evasion, targeting intrinsic, innate, and adaptive immunity. We have employed two orthogonal multiplexed tandem mass tag-based proteomic screens to identify host proteins down-regulated by viral factors expressed during the latest phases of viral infection. This approach revealed that the HIV-1 restriction factor Schlafen-11 (SLFN11) was degraded by the poorly characterized, late-expressed HCMV protein RL1, via recruitment of the Cullin4-RING E3 Ubiquitin Ligase (CRL4) complex. SLFN11 potently restricted HCMV infection, inhibiting the formation and spread of viral plaques. Overall, we show that a restriction factor previously thought only to inhibit RNA viruses additionally restricts HCMV. We define the mechanism of viral antagonism and also describe an important resource for revealing additional molecules of importance in antiviral innate immunity and viral immune evasion.</abstract><cop>United States</cop><pub>National Academy of Sciences</pub><pmid>35105802</pmid><doi>10.1073/pnas.2108173119</doi><tpages>7</tpages><orcidid>https://orcid.org/0000-0001-8429-8374</orcidid><orcidid>https://orcid.org/0000-0001-9407-1974</orcidid><orcidid>https://orcid.org/0000-0002-6799-1182</orcidid><orcidid>https://orcid.org/0000-0003-0467-8989</orcidid><orcidid>https://orcid.org/0000-0003-3196-5545</orcidid><orcidid>https://orcid.org/0000-0001-7313-9247</orcidid><orcidid>https://orcid.org/0000-0001-9958-4699</orcidid><orcidid>https://orcid.org/0000-0002-4991-9128</orcidid><orcidid>https://orcid.org/0000-0002-6738-0066</orcidid><orcidid>https://orcid.org/0000-0002-0000-5712</orcidid><orcidid>https://orcid.org/0000-0003-0093-7170</orcidid><orcidid>https://orcid.org/0000-0002-2243-4964</orcidid><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 0027-8424
ispartof Proceedings of the National Academy of Sciences - PNAS, 2022-02, Vol.119 (6), p.1-7
issn 0027-8424
1091-6490
language eng
recordid cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_8832970
source MEDLINE; PubMed Central; Alma/SFX Local Collection; Free Full-Text Journals in Chemistry
subjects Adaptive immunity
Biological Sciences
Cytomegalovirus
Cytomegalovirus - genetics
Cytomegalovirus - immunology
Cytomegalovirus Infections - genetics
Cytomegalovirus Infections - immunology
HIV
Human immunodeficiency virus
Humans
Immune Evasion
Immunity
Innate immunity
Nuclear Proteins - genetics
Nuclear Proteins - immunology
Plaques
Proteins
Proteolysis
Proteomics
Recruitment
RNA viruses
Ubiquitin
Ubiquitin-protein ligase
Ubiquitin-Protein Ligase Complexes - genetics
Ubiquitin-Protein Ligase Complexes - immunology
Viral Envelope Proteins - genetics
Viral Envelope Proteins - immunology
Viral infections
title Human cytomegalovirus protein RL1 degrades the antiviral factor SLFN11 via recruitment of the CRL4 E3 ubiquitin ligase complex
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-06T16%3A56%3A11IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-jstor_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Human%20cytomegalovirus%20protein%20RL1%20degrades%20the%20antiviral%20factor%20SLFN11%20via%20recruitment%20of%20the%20CRL4%20E3%20ubiquitin%20ligase%20complex&rft.jtitle=Proceedings%20of%20the%20National%20Academy%20of%20Sciences%20-%20PNAS&rft.au=Nightingale,%20Katie&rft.date=2022-02-08&rft.volume=119&rft.issue=6&rft.spage=1&rft.epage=7&rft.pages=1-7&rft.issn=0027-8424&rft.eissn=1091-6490&rft_id=info:doi/10.1073/pnas.2108173119&rft_dat=%3Cjstor_pubme%3E27118546%3C/jstor_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2628327746&rft_id=info:pmid/35105802&rft_jstor_id=27118546&rfr_iscdi=true